Genelux GNLX
NASDAQ GNLX
$2.04 -0.03 (-1.45%)
As of: Oct 22, 2026 · 12:48 PM EDT

Genelux (GNLX) Net Margin (2022 - 2024)

Updated

Genelux (GNLX) reported Net Margin of -401812.50% for FY2025, down 28450.00 percentage points from -373362.50% in FY2024.

Analysis

Genelux (GNLX) Net Margin (2022 - 2024) Analysis & Trends

Dating back to FY2022, Genelux's Net Margin record includes 4 years.

  • Net Margin has declined for three consecutive years, with a three-year change of -401765.45 percentage points (FY2022 to FY2025).
  • According to Business Quant data, Net Margin came in at -373362.50% in FY2024 (-356717.21 pp), -16645.29% in FY2023 (-16598.25 pp) and -47.05% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,169.59 Bn 1,138.18 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 643.18 Bn 561.71 Bn 17.26 Bn 21.86%
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn 21.27%
4 Merck 361.55 Bn 315.92 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.33 Bn 266.32 Bn 11.24 Bn 22.65%
6 Astrazeneca 267.31 Bn 241.00 Bn 12.86 Bn 16.30%
7 Amgen 241.52 Bn 196.92 Bn 7.24 Bn 23.62%
8 Gilead Sciences 193.17 Bn 167.37 Bn 6.22 Bn -134.51%
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn -1.65%
10 Genelux 89.63 Mn 27.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -98,125.00%
Mar 31, 2023 -6,096.47%
Dec 31, 2022 -5,139.71%
Sep 30, 2022 44.63%
API Access

Genelux Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=GNLX&period=max&api_key=YOUR_API_KEY